Abstract
In Alzheimer disease (AD), the microtubule-associated protein tau is highly phosphorylated and aggregates into characteristic neurofibrillary tangles. Prostate-derived sterile 20-like kinases (PSKs/TAOKs) 1 and 2, members of the sterile 20 family of kinases, have been shown to regulate microtubule stability and organization. Here we show that tau is a good substrate for PSK1 and PSK2 phosphorylation with mass spectrometric analysis of phosphorylated tau revealing more than 40 tau residues as targets of these kinases. Notably, phosphorylated residues include motifs located within the microtubule-binding repeat domain on tau (Ser-262, Ser-324, and Ser-356), sites that are known to regulate tau-microtubule interactions. PSK catalytic activity is enhanced in the entorhinal cortex and hippocampus, areas of the brain that are most susceptible to Alzheimer pathology, in comparison with the cerebellum, which is relatively spared. Activated PSK is associated with neurofibrillary tangles, dystrophic neurites surrounding neuritic plaques, neuropil threads, and granulovacuolar degeneration bodies in AD brain. By contrast, activated PSKs and phosphorylated tau are rarely detectible in immunostained control human brain. Our results demonstrate that tau is a substrate for PSK and suggest that this family of kinases could contribute to the development of AD pathology and dementia.
Highlights
Neurofibrillary tangles comprising abnormally phosphorylated tau are hallmarks for Alzheimer disease
We found that PSK1-␣/ and PSK2 both phosphorylated human tau directly in these in vitro kinase assays, demonstrating that tau is a substrate for both of these kinases (Fig. 1B)
We have shown that Prostate-derived sterile 20-like kinases (PSKs) are activated in tangle-bearing neurons in Alzheimer disease (AD) brain tissues and that tau is a substrate for these kinases
Summary
Neurofibrillary tangles comprising abnormally phosphorylated tau are hallmarks for Alzheimer disease. Serine 181; tau-Ser(P)-262/356, tau phosphorylated on serine 262 and/or 356; NFT, neurofibrillary tangle; AD, Alzheimer disease; TAOK, thousand and one amino acid kinase; MARK, microtubule affinity-regulating kinase; GSK3, glycogen synthase kinase-3; FTDP-17, familial frontotemporal dementia with Parkinsonism linked to chromosome 17; PHF, paired helical filament. PSKs are activated catalytically in regions of the brain that are susceptible to AD pathology and are present in intraneuronal NFTs, neuropil threads, and granulovacuolar degeneration bodies where tau is phosphorylated Each of these structures is characteristic for AD, and our findings suggest potential roles for these proteins in the development of AD and neurodegeneration
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.